Colonoscopy is the most widely used primary screening test for CRC in the U.S., and is the final common exam for all screening modalities. Thus, optimizing colonoscopy performance is crucial for CRC screening programs, regardless of initial screening method. The overall goal of Project 2 is the optimization of colonoscopy exams for colorectal cancer (CRC) to deliver screening: tailored to risk (patient-centered), that is efficient &timely (without over-screening), and effective (maximizing the impact of each exam on risk reduction). The specific goal is to identify failures of colonoscopy screening, characterize potentially modifiable factors for failures, and conduct exploratory studies concerning interventions for minimizing failures. Two of the most important problems in using colonoscopy are under-diagnosis (interval cancers despite screening) and surveillance overuse (at more frequent intervals than guidelines suggest);both are failures for an efficient, effective, and patient-centered screening program. Although a relatively common cancer, only a few percent of the population will die from CRC;thus colonoscopy for most patients results in unnecessary risk, expense, and worry without a potential for benefit. However, among those developing CRC, a significant number had a pre-cancer exam which failed to detect/prevent their cancer: possible failures of detection, or potentially, cancers with a different biology which eluded standard detection methods or exam intervals. Our center will address these problems through a series of investigations in a very large, diverse, community-based population: 1. An evaluation of overall patterns of test use including: screening failures, surveillance failures (CRC developing despite surveillance), and surveillance overuse. 2. An evaluation of quality factors associated with screening failures, including establishment of community-based normative values for quality measures (e.g. adenoma detection rates), testing of methods to adjust adenoma detection rates for patient mix to permit valid comparisons between physicians in different practice settings, and investigation of the associations between different rates and the subsequent risk of CRC for the establishment of quality improvement targets in U.S. populations. 3. Investigation of physician, patient, and healthcare system factors related to the failure, overuse, and quality patterns found in Alms 1 and 2 using a recently developed, systematic, multi-step process for implementing effective performance Interventions in health care settings. At the end of this project, we will have: a) overall patterns of test use and failures;b) modifiable variables that predict high, medium and low performers for certain quality measures;c) identified which modifiable variables to target;d) evaluated what interventions stakeholders would support and e) test piloted interventions that have the greatest potential to be effective for each factor.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163262-04
Application #
8715703
Study Section
Special Emphasis Panel (ZCA1-SRLB-R)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
4
Fiscal Year
2014
Total Cost
$553,294
Indirect Cost
$100,218
Name
Kaiser Foundation Research Institute
Department
Type
DUNS #
150829349
City
Oakland
State
CA
Country
United States
Zip Code
94612
Klabunde, Carrie N; Zheng, Yingye; Quinn, Virginia P et al. (2016) Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med 51:e67-75
Chubak, Jessica; Garcia, Michael P; Burnett-Hartman, Andrea N et al. (2016) Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev 25:344-50
Burnett-Hartman, Andrea N; Mehta, Shivan J; Zheng, Yingye et al. (2016) Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med 51:e107-15
McCarthy, Anne Marie; Kim, Jane J; Beaber, Elisabeth F et al. (2016) Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. Am J Prev Med 51:507-12
Jensen, Christopher D; Corley, Douglas A; Quinn, Virginia P et al. (2016) Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med 164:456-63
Lee, Jeffrey K; Corley, Douglas A (2016) What makes a ""good"" colonoscopy quality indicator? Gastrointest Endosc 83:179-81
Lee, Alexander; Jensen, Christopher D; Marks, Amy R et al. (2016) Endoscopist Fatigue Estimates and Colonoscopic Adenoma Detection in a Large Community-Based Setting. Gastrointest Endosc :
Kim, Jane J; Tosteson, Anna Na; Zauber, Ann G et al. (2016) Cancer Models and Real-world Data: Better Together. J Natl Cancer Inst 108:
Tosteson, Anna N A; Beaber, Elisabeth F; Tiro, Jasmin et al. (2016) Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med 31:372-9
Meester, Reinier G S; Zauber, Ann G; Doubeni, Chyke A et al. (2016) Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol 14:1445-1451.e8

Showing the most recent 10 out of 30 publications